ArticleHealth science reports2025

Safe Switch to an Oral Two-Drug Regimen Based on Dolutegravir in People With Vertically Acquired HIV-1: An Observational Multicenter Study.

Giulia Meraviglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.